194700 — Novarex Co Balance Sheet
0.000.00%
- KR₩199bn
- KR₩194bn
- KR₩298bn
- 72
- 64
- 91
- 90
Annual balance sheet for Novarex Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | — | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 36,236 | 19,201 | 39,644 | 30,699 | 31,192 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 31,533 | 44,363 | 39,241 | 55,091 | 52,323 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 100,066 | 111,653 | 129,465 | 121,852 | 142,290 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 99,591 | 125,222 | 128,023 | 128,170 | 128,795 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 215,501 | 254,633 | 270,581 | 264,734 | 289,610 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 57,761 | 89,443 | 72,524 | 60,062 | 66,062 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 99,891 | 114,965 | 89,461 | 64,501 | 70,354 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 115,609 | 139,668 | 181,120 | 200,233 | 219,256 |
Total Liabilities & Shareholders' Equity | 215,501 | 254,633 | 270,581 | 264,734 | 289,610 |
Total Common Shares Outstanding |